Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

Update Il y a 4 ans
Reference: NCT00134511

Woman and Man

Extract

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. To evaluate the efficacy and safety of the lipid drug Torcetrapib/atorvastatin in patients with genetically known disorder of extremely high cholesterol


Inclusion criteria

  • Hypercholesterolemia, Familial

Links